Phillies Rojas Suspended 80 Games After Failed PED Test, Missing World Baseball Classic

Philadelphia Phillies utility infielder Johan Rojas received devastating news Tuesday as Major League Baseball announced an 80-game suspension following a positive test for performance-enhancing drugs. The suspension not only sidelines the 25-year-old for nearly half of the 2026 season but also eliminates his opportunity to represent his home country in the upcoming World Baseball Classic.

Rojas tested positive for an undisclosed banned substance during spring training, marking his first violation of MLBs Joint Drug Prevention and Treatment Program. The 80-game suspension without pay represents the standard penalty for a first-time PED offense and will cost the infielder approximately $1.2 million in lost salary. MLB has not revealed the specific substance involved, citing privacy protocols established in the leagues drug testing agreement.

The timing of the suspension is particularly crushing for Rojas, who had been selected to represent the Dominican Republic in the World Baseball Classic. The tournament, which begins later this month, represented a significant honor for the young player and an opportunity to showcase his talents on the international stage. Dominican Republic manager Tony Peña expressed disappointment over losing Rojas but emphasized the teams commitment to clean competition.

Phillies general manager Dave Dombrowski addressed the suspension during a hastily arranged press conference, expressing the organizations disappointment while reaffirming their zero-tolerance policy regarding performance-enhancing drugs. The executive indicated that the team was completely unaware of any substance use by Rojas and stressed that the organization provides extensive education about banned substances to all players throughout their development.

Rojas had been competing for a utility role with the Phillies after spending most of 2025 bouncing between Triple-A Lehigh Valley and the major league roster. The versatile infielder, who can play multiple positions, had shown promise during limited opportunities with Philadelphia, posting a .267 batting average with three home runs in 45 games last season. His suspension now opens up roster spots and playing time for other prospects within the organizations system.

The suspension adds Rojas to a growing list of players who have faced PED penalties in recent years, highlighting the ongoing challenges Major League Baseball faces in maintaining the integrity of the sport. While testing has significantly reduced the prevalence of performance-enhancing drug use compared to previous decades, cases like Rojas serve as reminders that the issue persists. The infielder will be eligible to return to the Phillies in mid-July, provided he completes the required counseling and testing protocols established by the leagues drug program.